All Stories

  1. The origins, etymology and meaning of metastasis in the context of cancer.
  2. Geotherapeutics: the medicinal use of earths, minerals and metals from antiquity to the twenty-first century
  3. Gods behaving badly
  4. Ipilimumab and Vemurafenib in melanoma
  5. Medical experiments in antiquity
  6. Alexander the Great and his interest in medicine
  7. Adjuvant vindesine in metastatic melanoma
  8. Heredopathia atactica polyneuritiformis: Refsum's disease
  9. Reflecting on the 2001 American Joint Committee on Cancer Staging System for Melanoma
  10. Sentinel node biopsy confers no added protection to patients with melanoma
  11. Sentinel node biopsy confers no added protection to patients with melanoma
  12. INV 9 Prognostic factors of cutaneous melanoma and the latest staging system of the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients from a single institution
  13. Integration of gamma knife surgery in the management of cerebral metastases from melanoma
  14. In Reply:
  15. Cutaneous melanoma
  16. Cutaneous melanoma
  17. Randomised clinical trials in Cancer Research
  18. 12 Systemic treatment of metastatic melanoma: current options
  19. can viruses cause melanoma?
  20. P-13 Serum HER-2/neu concentrations in metastatic melanoma
  21. Report on the 5th International Conference on the Adjuvant Therapy of Malignant Melanoma held in Athens, Greece, 18–20 March, 2004
  22. Systemic Treatments For Metastatic Melanoma
  23. The CDKN2A tumour suppressor gene
  24. Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanoma held at the Royal College of Physicians, London, UK, 15–16 March 2002
  25. Overexpression of HER-2 in thick melanoma
  26. Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC)
  27. Adjuvant therapy of malignant melanoma: is there a choice?
  28. Prognostic factors in therapeutic lymphadenectomy in melanoma
  29. What is the Optimal Therapy of Brain Metastases?
  30. What is the Optimal Therapy of Brain Metastases?
  31. Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma
  32. In Vitro Cytotoxicity of Norviburtinal and Isopinnatal from Kigelia pinnata Against Cancer Cell Lines
  33. Oxaliplatin is active in vitro against human melanoma cell lines: comparison with cisplatin and carboplatin
  34. Melanoma and additional primary cancers
  35. Melanoma and additional primary cancers
  36. Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma
  37. 9 Melanoma and additional primary cancers
  38. O10 Serum S-100 protein as a marker of disease activity in malignant melanoma (MM)
  39. P29 Detection of tyrosinase mRNA by RT-PCR in peripheral blood of patients with melanoma
  40. 24 Adjuvant therapy for malignant melanoma. Is there a choice?
  41. Sentinel-Lymph-Node Biopsy
  42. Adjuvant therapy of melanoma
  43. Dissection of regional lymph nodes in cutaneous melanoma
  44. 2nd International Conference on the AdjuvantTherapy of Malignant Melanoma London, UK, 14–15 March, 1997
  45. 7 Adjuvant therapy of malignant melanoma; the unreachable goal?
  46. 21 Activity of Taxanes combined with Vinorelbine in disseminated malignant melanoma
  47. 22 Adjuvant Vindesine in malignant melanoma (MM); 20 years on
  48. 45 Activity of Docetaxel (D) and Vinorelbine (V) in vitro against human melanoma cell lines
  49. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines
  50. Systemic treatment of malignant melanoma: grade is as important as stage
  51. Systemic treatment of malignant melanoma: grade is as important as stage
  52. The combination of paclitaxel with cisplatin exhibits antagonism in vitro against human melanoma
  53. Adjuvant interferon alfa-2b for high-risk melanoma.
  54. Fertility after prolonged chemotherapy for metastatic malignant disease
  55. Taxol and vinorelbine
  56. Cutaneous Melanoma-Associated Retinopathy
  57. Taxol and vinorelbine: a new active combination for disseminated malignant melanoma
  58. Malignant melanoma co-existing with sarcoidosis: implications for prognosis and management
  59. 1st International Conference on the Adjuvant Therapy of Malignant Melanoma
  60. 5 Clinical observations on the biology of malignant melanoma
  61. 16 Clinical and histological involvement of regional lymph nodes in malignant melanoma
  62. Cutaneous Melanoma-associated Retinopathy
  63. Activity of Extracts ofKigelia pinnataAgainst Melanoma and Renal Carcinoma Cell Lines
  64. Pharmaceuticals from plants
  65. Adjuvant interferon in melanoma
  66. Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survival
  67. Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines
  68. Metastasis to the penis from malignant melanoma: Case report and review of the literature
  69. α-Interferons: Impact on survival of patients with renal cell carcinoma
  70. Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy
  71. α-interferons: Impact on survival of patients with renal cell carcinoma
  72. Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma.
  73. Central nervous system lnvolvement in malignant melanoma
  74. EARLY OR LOW-GRADE MELANOMA?
  75. Missed malignant melanoma
  76. Missed malignant melanoma
  77. Missed malignant melanoma
  78. Missed malignant melanoma
  79. Malignant Melanoma: Prolonged Survival after Cerebral Metastasis
  80. Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
  81. Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy
  82. Sun beds and melanoma.
  83. Pigment streaks in the nail plate due to secondary malignant melanoma
  84. Evaluation of human lymphoblastoid interferon in advanced malignant melanoma
  85. Updated results of vindesine as a single agent in the therapy of advanced malignant melanoma
  86. HEREDOPATHIA ATACTICA POLYNEURITIFORMIS (REFSUM'S DISEASE) TREATED BY DIET AND PLASMA-EXCHANGE
  87. Vindesine as a single agent in the treatment of advanced malignant melanoma
  88. Vinca Alkaloids and Platelets
  89. AGRANULOCYTOSIS IN BREAST-CANCER PATIENTS TREATED WITH LEVAMISOLE
  90. Symptom relief with levamisole in stage IV Hodgkin's disease.
  91. Successful bone marrow transplant for Fanconi's anaemia.
  92. Insulin abuse by a drug addict.